CITA Biomedical Licenses UROD Treatment to Eden Medical Center.Business Editors & Health/Medical Writers BEVERLY HILLS, Calif.--(BUSINESS WIRE)--Jan. 31, 2001 CITA CITA Committee for the Implementation of Textile Agreements CITA Canadian Institute for Theoretical Astrophysics CITA Center for Information Technology Accommodation (US; now the GSA IT Accommodation Division) Biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :DTOX) a growing leader in the treatment of addiction dependency, today announced that it has signed a license agreement with Eden Medical Center. The agreement enables Eden Medical Center to provide CITA's U.S. patented Ultra Rapid Opiate opiate /opi·ate/ (o´pe-it) 1. any drug derived from opium. 2. hypnotic (2). o·pi·ate n. 1. Detoxification Detoxification Definition Detoxification is one of the more widely used treatments and concepts in alternative medicine. It is based on the principle that illnesses can be caused by the accumulation of toxic substances (toxins) in the body. (UROD UROD Ultra-Rapid Opiate Detoxification (R)) treatment method to patients in the San Francisco Bay Area “Bay Area” redirects here. For other uses, see Bay Area (disambiguation). The San Francisco Bay Area, colloquially known as the Bay Area or The Bay . "We are pleased to add the UROD(R) treatment method as an option for our patients and community," said George Bischalaney, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Eden Medical Center. "Because this will be the only service of its kind in this area, our community will have the most advanced and effective treatment options that were once out of reach. More important, the service will be provided in the hospital setting and safely administered by Eden's anesthesiologists." "We are pleased to be working with Eden Medical Center, and its highly competent medical staff, to provide the UROD(R) treatment method to their community," said Joseph Dunn, president and CEO of CITA Biomedical. "The recently granted UROD(R) patent allows us to open facilities at a much faster rate, which in turn increases our revenue stream. "We feel that, with this combination, CITA is well positioned to take the UROD(R) treatment method into the mainstream, worldwide, as the safest, most successful solution for patients to overcome drug addiction." UROD(R) is the only clinically tested and effective treatment method to rapidly detoxify de·tox·i·fy v. 1. To counteract or destroy the toxic properties of a substance. 2. To remove the effects of poison from something, such as the blood. 3. individuals addicted to opiate-based drugs, including heroin, within four to six hours with little or no withdrawal symptoms Withdrawal symptoms A group of physical or mental symptoms that may occur when a person suddenly stops using a drug to which he or she has become dependent. . The treatment provides a safe and humane detoxification approach for patients, making it a far less painful recovery process than currently offered alternatives. This approach significantly enhances motivation for individuals who wish to overcome addiction. CITA also offers a comprehensive, one-year continuing care continuing care a professional convention that a veterinarian who is treating an animal is obliged to continue treating that case unless an arrangement is made with its custodian to transfer the care to another practitioner or to a specialist. program -- FIT(SM) (Flexible Intensity Treatment). After the UROD(R) procedure, the patient embarks on a six-month medication and ongoing therapy regimen. The aftercare af·ter·care n. Follow-up care provided after a medical procedure or treatment program. aftercare the care and treatment of a convalescent patient, especially one that has undergone surgery. medication works by blocking opiate receptors in the central nervous system, allowing for continued repair and regeneration. Unlike alternative processes, the medication used in the FIT process is not a substitute for heroin or other opiates Opiates Analgesic, pain killing drugs, such as heroin and morphine that depress the central nervous system. Mentioned in: Withdrawal Syndromes , and creates no further dependency. In fact, while on the aftercare medication, if a patient uses opiates again, the euphoric "high" is not experienced. In addition to general therapy-related services, a key component of its continuing care program is www.CubeCentral.com -- CITA's Web-based community portal. The portal was created to provide a host of products, support and services designed to aid addicts and recovering addicts, as well as family, friends and professionals who may be affected by addiction and addiction recovery. The UROD(R) Method has been featured in the storylines of popular television programs, such as "ER, "Chicago Hope" and "General Hospital," and previewed on ABC's "20/20," Fox News, Discover Wall Street and World Business Review. About Eden Medical Center Eden Medical Center is a 275-bed not-for-profit hospital serving the San Francisco Bay Area and is the regional trauma center for southern Alameda County. Eden is affiliated with Sutter Health, the largest network of nonprofit hospitals in Northern California that includes 27 hospitals and nearly 4,000 physicians. The medical center offers a continuum of medical, surgical, psychiatric and rehabilitative services in a community setting. For more information, visit www.edenmedcenter.org. About CITA Biomedical CITA Biomedical Inc., with headquarters in Beverly Hills, focuses on investigation and treatment of addiction. The company grows its business through internal expansion and seeks compatible, competitive and complementing technologies and acquisitions to enhance its corporate portfolio. CITA Biomedical has two operating divisions CITA Americas Inc. and CubeCentral.com Inc. For more information, visit www.citabio.com. The information contained in this news release includes forward-looking statements. Forward-looking statements include declarations concerning plans, objectives, goals, strategies, future events and/or performance, and underlying assumptions and other statements which are other than statements of historical facts. Forward-looking statements usually contain the words "estimate," "anticipate," "believe," "expect" and other similar expressions that involve risks and uncertainties. These risks and uncertainties include, but are not limited to, the company's status as a start-up enterprise with uncertain profitability, its need for significant capital, limited facilities, competition, uncertainty as to market acceptance of its services, and the protection of its intellectual property. The company's actual results could differ materially from those expressed or implied in any forward-looking statements. Note to Editors: UROD is a registered trademark of CITA Biomedical Inc. FIT is a service mark of CITA Biomedical Inc. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion